UK trial assessing AZ’ AZD1775 in head and neck cancer

27th November 2017 Uncategorised 0

A clinical trial testing AstraZeneca’s experimental drug AZD1775, an inhibitor of the cell cycle regulating protein WEE1, in patients with head and neck cancer has now launched in the UK.

More: UK trial assessing AZ’ AZD1775 in head and neck cancer
Source: News